Among nearly 200,000 patients hospitalized with COVID-19, mortality declined from 22.1% in March to 6.5% in August of 2020.
While <20% of patients with SARS-CoV-2 infection require hospitalization, the large total number of infected individuals has resulted in thousands of hospital admissions. Investigators used a U.S. clinical database to describe the characteristics and outcomes of 192,550 adults (52.5% men, 43.3% white) hospitalized with COVID-19 at 555 medical centers between March 1 and August 31, 2020.
The most common comorbidities were hypertension (61.5%), diabetes (38.4%), and obesity (27.4%). In-hospital mortality was 13.6% overall, rising with age (from 1.4% [age range, 18–29] to 26.6% [≥80]) and falling with calendar month (from 22.1% [March] to 6.5% [August]). Almost 30% of the cohort was admitted to the intensive care unit (ICU); of these patients, …
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)